Work

Taking action early to manage emergence of acquired resistance to osimertinib or other third generation EGFR inhibitors

Year: 2021

Type: article

Source: Oncoscience

DOI: 10.18632/oncoscience.544

Authors: Guangzhi Ma, Shi-Yong Sun

Institutions: Emory University, Winship Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W3200534754

FWCI: 0.285

Cites: 11

Cited by: 3

Related to: 10